Comparison of the effect of homocysteine and its thiolactone on the fibrinolytic system using human plasma and purified plasminogen

Molecular and Cellular Biochemistry

Volumn 344, Issue 1-2, 2010, Pages 217-220

  Kołodziejczyk, Joanna ^a   Malinowska, Joanna ^a   Nowak, Pawel ^a   Olas, Beata ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; PLASMINOGEN;

ADULT; COMPARATIVE STUDY; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; NORMAL HUMAN; PLASMA; PROTEIN DEGRADATION; SHORT SURVEY;

ADULT; FIBRINOLYSIS; HOMOCYSTEINE; HUMANS; LACTONES; PLASMINOGEN;

EID: 78449296668     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0545-z     Document Type: Short Survey

References (12)

1. H Jakubowski 2007 The molecular basis of homocysteine thiolactone-mediated vascular disease Clin Chem Lab Med 12 1704 1716 10.1515/CCLM.2007.338
2. K Karolczak B Olas 2009 Mechanism action of homocysteine and its thiolactone in haemostasis system Physiol Res 58 1 11
3. DG Deutch ET Mertz 1970 Plasminogen: purification from human plasma by affinity chromatography Proc Natl Acad Sci USA 61 636 643
4. R Glowacki K Wójcik E Bald 2001 Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection J Chromatogr 914 29 35 1:CAS:528:DC%2BD3MXisVansro%3D 10.1016/S0021-9673(00)01064-5
5. E Bald G Chwatko R Glowacki, et al. 2004 Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection J Chromatogr 1032 109 115 1:CAS:528:DC%2BD2cXhslCis7g%3D 10.1016/j.chroma.2003.11.030
6. T Krajewski P Nowak C Cierniewski 1985 Terminal plasmin degradation products D and E of duck fibrinogen and their effect on polymerization of fibrin Acta Biochim Pol 32 144 154 1:STN:280:DyaL2Mzgt1ygtQ%3D%3D 4036448
7. DL Sauls AS Wolberg M Hoffman 2003 Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia J Thromb Haemost 1 300 306 1:CAS:528:DC%2BD2cXktFemsro%3D 10.1046/j.1538-7836.2003.00053.x 12871504
8. R Marchi Z Carvajal JW Weisel 2008 Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen Thromb Haemostasis 99 451 452 1:CAS:528:DC%2BD1cXisFKmtLg%3D
9. Malinowska J, Nowak P, Olas B. Comparison of the effect of the reduced form homocysteine and its thiolactone on hemostatic properties of plasma and fibrinogen. MCB (submitted)
10. DL Sauls E Lockhart ME Warren, et al. 2006 Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia Biochem 45 2480 2488 1:CAS:528:DC%2BD28XpvFGhtg%3D%3D 10.1021/bi052076j
11. DL Sauls EK Arnold CW Bell, et al. 2007 Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia Thromb Res 120 117 126 1:CAS:528:DC%2BD2sXksFeju7g%3D 10.1016/j.thromres.2006.08.001 16979225
12. AT Jacovina AB Deora Q Ling, et al. 2009 Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis J Clin Invest 119 3384 3394 1:CAS:528:DC%2BD1MXhtlOitrbN 19841537